Literature DB >> 16584708

In situ characterization of lipid A interaction with antimicrobial peptides using surface X-ray scattering.

Frances Neville1, Chris S Hodges, Chao Liu, Oleg Konovalov, David Gidalevitz.   

Abstract

Lipid A structure at the air-aqueous interface has been studied using pressure-area isotherm methods coupled with the surface X-ray scattering techniques of X-ray reflectivity (XR) and grazing incidence X-ray diffraction (GIXD). Lipid A monolayers were formed at the air-aqueous interface to represent the lipid moiety of the outer membrane of Gram-negative bacteria. Lipid A structure was characterized at surface pressures between 10 and 35 mN/m. Interactions of alpha-helical antimicrobial peptides LL-37, SMAP-29 and D2A22 with lipid A monolayers were subsequently studied. Although insertion into the lipid A monolayers was observed with the alpha-helical peptides, little change was seen from the X-ray data, suggesting that the lipid A hydrocarbon chains are involved in reorientation during insertion and that the hydrocarbon chains have a relatively rigid structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584708     DOI: 10.1016/j.bbamem.2006.01.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Role of the conformational rigidity in the design of biomimetic antimicrobial compounds.

Authors:  Andrey Ivankin; Liran Livne; Amram Mor; Gregory A Caputo; William F Degrado; Mati Meron; Binhua Lin; David Gidalevitz
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

2.  Antibacterial properties and mode of action of a short acyl-lysyl oligomer.

Authors:  Fadia Zaknoon; Hadar Sarig; Shahar Rotem; Liran Livne; Andrey Ivankin; David Gidalevitz; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

Review 3.  Peptoid drug discovery and optimization via surface X-ray scattering.

Authors:  Konstantin Andreev; Michael W Martynowycz; David Gidalevitz
Journal:  Biopolymers       Date:  2019-03-20       Impact factor: 2.505

4.  Effects of specific versus nonspecific ionic interactions on the structure and lateral organization of lipopolysaccharides.

Authors:  Christoph Jeworrek; Florian Evers; Jörg Howe; Klaus Brandenburg; Metin Tolan; Roland Winter
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

5.  Salmonella Membrane Structural Remodeling Increases Resistance to Antimicrobial Peptide LL-37.

Authors:  Michael W Martynowycz; Amy Rice; Konstantin Andreev; Thatyane M Nobre; Ivan Kuzmenko; Jeff Wereszczynski; David Gidalevitz
Journal:  ACS Infect Dis       Date:  2019-05-24       Impact factor: 5.084

6.  Protegrin interaction with lipid monolayers: Grazing incidence X-ray diffraction and X-ray reflectivity study.

Authors:  Frances Neville; Yuji Ishitsuka; Chris S Hodges; Oleg Konovalov; Alan J Waring; Robert Lehrer; Ka Yee C Lee; David Gidalevitz
Journal:  Soft Matter       Date:  2008       Impact factor: 3.679

7.  A comparative study on the interactions of SMAP-29 with lipid monolayers.

Authors:  Frances Neville; Andrey Ivankin; Oleg Konovalov; David Gidalevitz
Journal:  Biochim Biophys Acta       Date:  2009-10-02

8.  Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol.

Authors:  Andrey Ivankin; Beatriz Apellániz; David Gidalevitz; José L Nieva
Journal:  Biochim Biophys Acta       Date:  2012-06-09

Review 9.  Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.

Authors:  Kornelius Zeth; Enea Sancho-Vaello
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Structural characterization of a model gram-negative bacterial surface using lipopolysaccharides from rough strains of Escherichia coli.

Authors:  Anton P Le Brun; Luke A Clifton; Candice E Halbert; Binhua Lin; Mati Meron; Peter J Holden; Jeremy H Lakey; Stephen A Holt
Journal:  Biomacromolecules       Date:  2013-05-09       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.